VP US Anti-Infectives Portfolio
GlaxoSmithKline LLC - Philadelphia, PA
Apply NowJob Description
Reference #: 404769 Site Name: USA - North Carolina - Durham, USA - Pennsylvania - Philadelphia Posted Date: Sep 19 2024 GSK has bold commercial ambitions for the future. By 2031, we aim to deliver 38 billion in annual sales - building from existing strong performance momentum which will significantly increase the positive impact we can have on the health of billions of patients around the world. Our Ahead Together strategy means intervening early to prevent and change the course of disease, helping to protect people and support healthcare systems. Our portfolio is made up of vaccines, specialty medicines and general medicines, to prevent and treat disease, many with the potential to be first-or best-in-class. GSK has been developing and supplying antibiotics for more than 70 years and is already a leader on the Antimicrobial Resistance (AMR) Benchmark of the Access to Medicine Foundation. We are committed to investing in solutions to help get ahead of antimicrobial resistance, and we participate in the AMR Action Fund, which aims to bring2-4 new antibioticsto patientsby 2030 through sustainable investment in the antibiotic pipeline. In addition to our legacy in antibiotics, infectious diseases and HIV represent around two-thirds of GSK's current pipeline, and we have a growing portfolio of late-stage antimicrobials, with three products anticipated to launch on the US market by the end of 2026. Job purpose This role combines Sales, Marketing and P&L leadership responsibilities for the Anti-Infectives portfolio in the US business. You will orchestrate and lead the establishment of an Anti-Infective business in the US, with a goal of bringing to market novel new antibiotic or antifungal assets in a therapeutic space where there has been little innovation in the last 2+ decades. This will include building a team and leading both short-term execution and mid-to-long term strategy for a portfolio of 3+ assets - to secure access, drive uptake in the US market, and drive portfolio growth in new product segments. You will have full P&L accountability for this portfolio and will provide strategic direction and managerial oversight to teams of marketers and customer facing roles. You will also serve on the US Anti-infective & Respiratory business Leadership Team (AIR LT), and interface with the US Commercial Executive Team. This role is based at one of our US commercial hub sites, in either Durham NC or Philadelphia PA, and candidates should expect to be present in the office for at least 2-3 days per week. Key responsibilities Senior management of an expanding marketing and sales function, and matrix leadership of cross-functional partners including medical, regulatory, legal, compliance. Responsible for all aspects of commercialization for a portfolio of at least 3 launch products. Develop, implement, and execute short-term and long-term strategy and business objectives for the Anti-infectives business. Manage business operations end to end with complete responsibility for the top and bottom line, cash flow, and return on capital. Drive business development, business transformation, and continuous improvement initiatives. Accountable for achieving forecast goals, and operating profit. Allocates SG&A budget via Operational Planning process, and monitors budget effectively throughout the year to minimize waste and maximize return. Develop a strong leadership pipeline; recruit, develop and retain a high caliber team across diverse departments. Develop and execute GSK Anti-infective Business strategy for the appropriate patients including input on medical, access and BD efforts to support the overall AIR business strategy. Lead your team to effectively execute strategy and tactical plan by orchestrating partnerships and activities across a large matrix organization including Medical, Legal, Regulatory, Insights & Analytics, Market Access, Global Marketing, and other local and lobal teams. Approve, in partnership with Forecasting and Finance, development of product volume and financial forecasts including Long Range Forecast, Annual Plan, and monthly Latest Estimates. Drive market expansion of products within the US across all products in portfolio and aggressively implement strategies to grow presence in future indications. Visibly lead our Values, talent management and engagement, and ensure strong individual career and leadership development plans. Additionally, contribute to broader enterprise-wide initiatives and opportunities via the AIR LT as well as the US Commercial executive team. Candidate Profile Basic qualifications Bachelor's degree or equivalent level qualification in Science, Business, Finance, or Marketing. Minimum of 15 years progressive experience, including both sales and marketing leadership within the pharmaceutical industry. Demonstrated experience of at least 2 years commercialising anti-biotic and/or anti-fungal pharmaceutical products in the US market. P&L management experience, including developing product strategies and product positioning programs. Senior leadership experience as a second-line leader. Experience in both direct line and matrix management and serving on leadership teams. Preferred qualifications MBA in Business Management / Sales / Marketing. At least 4 years of commercial experience in the anti-infectives field. Background in business unit leadership / general management. Understanding of the US managed marketplace including the ability to exhibit outstanding business judgement as demonstrated by a track record in planning, marketing, sales and analytical roles. Experience in market development and creating new market opportunities. Comprehensive understanding of market dynamics unique to US anti-infective marketplace (for example, launching branded assets in a largely generic market; experience in hospital-based setting; market access experience). Proven ability and credibility to influence at multiple levels to secure resources needed to build and support a new business capability. Track record of success leading and embedding change and inspirationally leading your team through periods of change. Please visit GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees. Why GSK? Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a special purpose - to unite science, technology and talent to get ahead of disease together - so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns - as an organisation where people can thrive. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it's also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be. A place where they can be themselves - feeling welcome, valued, and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together.
Created: 2024-09-23